 Ecolab Inc NYSE: ECL reported first-quarter FY22 sales growth of 13 year-on-year to 3.27 billion, beating the consensus of 3.20 billion. Sales from Global Industrial rose 12, Global Institutional Specialty climbed 19, Global Healthcare Life Sciences grew 29. 